Pharmas Seek Pay-For-Delay Suit Stay Pending High Court Input
A circuit split on the legality of so-called pay-for-delay pharmaceutical patent settlements requires the U.S. Supreme Court to tackle the issue before a trial court reconsiders an antitrust suit against Merck...To view the full article, register now.
Already a subscriber? Click here to view full article